Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 150 articles:
HTML format



Single Articles


    May 2022
  1. BEYAZ S, Ersoy Y, Bicki E, Ak T, et al
    Psychiatric comorbidity and quality of life in patients with drug hypersensitivity.
    Allergy Asthma Proc. 2022;43:234-242.
    PubMed     Abstract available


  2. BELLANTI JA, Settipane RA
    Eosinophilic esophagitis: from discovery to effective treatment.
    Allergy Asthma Proc. 2022;43:175-177.
    PubMed    


  3. CRAIG T, Feuersenger H, Pragst I, Dang J, et al
    Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
    Allergy Asthma Proc. 2022;43:202-208.
    PubMed     Abstract available


  4. SHER ER, Ross JA, Weine DM, Chandini Arjun A, et al
    Current and emerging therapies for eosinophilic esophagitis.
    Allergy Asthma Proc. 2022;43:178-186.
    PubMed     Abstract available


  5. LANG A, Balmert LC, Weiss M, Pongracic JA, et al
    Real world use of peanut component testing among children in the Chicago metropolitan area.
    Allergy Asthma Proc. 2022;43:226-233.
    PubMed     Abstract available


  6. CAN BOSTAN O, Cakmak ME, Kaya SB, Tuncay G, et al
    The association of timothy grass allergy and cat ownership on cat sensitization.
    Allergy Asthma Proc. 2022;43:220-225.
    PubMed     Abstract available


  7. DENG SJ, Wang J, Liu L, Zhang X, et al
    Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
    Allergy Asthma Proc. 2022;43:209-219.
    PubMed     Abstract available


    March 2022

  8. Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii.
    Allergy Asthma Proc. 2022;43:174.
    PubMed    


  9. DIEHL KC, Popadiuk CA, Agbese E, Leslie DL, et al
    Cost assessment of allergy procedures to improve high-value care implementation.
    Allergy Asthma Proc. 2022;43:168-172.
    PubMed     Abstract available


  10. VOELKER DH, Gonzalez-Estrada A, Park MA
    Female sex as a risk factor for penicillin drug allergy in the inpatient setting.
    Allergy Asthma Proc. 2022;43:163-167.
    PubMed     Abstract available


  11. RAMIREZ RM, Jacobs RL, Andrews CP
    Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.
    Allergy Asthma Proc. 2022;43:116-123.
    PubMed     Abstract available


  12. BELLANTI JA, Settipane RA
    Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
    Allergy Asthma Proc. 2022;43:93-95.
    PubMed    


  13. CHEPY A, Veron M, Gautier S, Farhat MM, et al
    Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.
    Allergy Asthma Proc. 2022;43:155-162.
    PubMed     Abstract available


  14. BEYAZ S, Demir S, Oztop N, Colakoglu B, et al
    How satisfactory is on-demand icatibant from the patients' perspective in real life?
    Allergy Asthma Proc. 2022;43:148-154.
    PubMed     Abstract available


  15. OZDEN SERTCELIK U, Damadoglu E, Karakaya G, Demir AU, et al
    Impact of socioeconomic factors and house cleaning on asthma control in women.
    Allergy Asthma Proc. 2022;43:140-147.
    PubMed     Abstract available


  16. KIM HS, Yang HJ, Song DJ, Lee YJ, et al
    Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
    Allergy Asthma Proc. 2022;43:133-139.
    PubMed     Abstract available


  17. WU G, Hu H, Zhang T, Zhang XD, et al
    Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
    Allergy Asthma Proc. 2022;43:124-132.
    PubMed     Abstract available


    January 2022
  18. MALLIORI S, Ntzounas A, Lampropoulos P, Koliofoti E, et al
    Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991-2018.
    Allergy Asthma Proc. 2022;43:e17-e24.
    PubMed     Abstract available



  19. Abstracts presented at the Eastern Allergy Conference, June 3-6, 2021, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:86-90.
    PubMed    


  20. HARADA K, Baker MG, Agarwal S
    Patient perspectives on penicillin allergy and testing.
    Allergy Asthma Proc. 2022;43:64-69.
    PubMed     Abstract available


  21. BUYUK YAYTOKGIL S, Kulhas Celik I, Karaatmaca B, Ginis T, et al
    Prognosis of food-induced anaphylaxis in children: A single-center real-life study.
    Allergy Asthma Proc. 2022;43:57-63.
    PubMed     Abstract available


  22. SERBES M, Sasihuseyinoglu AS, Ozcan D, Ufuk Altintas D, et al
    Clinical features of anaphylaxis in children.
    Allergy Asthma Proc. 2022;43:50-56.
    PubMed     Abstract available


  23. ALMODALLAL Y, Weaver AL, Joshi AY
    Population-based incidence of food allergies in Olmsted County over 17 years.
    Allergy Asthma Proc. 2022;43:44-49.
    PubMed     Abstract available


  24. AQUINO MR, Bingemann TA, Nanda A, Maples KM, et al
    Delayed allergic skin reactions to vaccines.
    Allergy Asthma Proc. 2022;43:20-29.
    PubMed     Abstract available


  25. YOUSEF E, Korotkaya Y, Simpson AB
    Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup.
    Allergy Asthma Proc. 2022;43:5-11.
    PubMed     Abstract available


  26. GRIVCHEVA-PANOVSKA V, Craig TJ, Longhurst H, Bara N, et al
    Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management.
    Allergy Asthma Proc. 2022;43:e1-e10.
    PubMed     Abstract available


  27. PITLICK MM, Joshi AY, Gonzalez-Estrada A, Chiarella SE, et al
    Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Allergy Asthma Proc. 2022;43:40-43.
    PubMed     Abstract available


  28. GALLAGHER MC, Haessler S, Pecoy-Whitcomb E, Bayuk J, et al
    Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Allergy Asthma Proc. 2022;43:37-39.
    PubMed     Abstract available


  29. MAGEN E, Yakov A, Green I, Israel A, et al
    Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
    Allergy Asthma Proc. 2022;43:30-36.
    PubMed     Abstract available


  30. GANTI P, Suman A, Chaudhary S, Sangha B, et al
    The effect of the socioeconomic status on the measurement of asthma control.
    Allergy Asthma Proc. 2022;43:e11-e16.
    PubMed     Abstract available


  31. MCMURRAY JC, Clair BS, Spriet SW, Min SB, et al
    Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic.
    Allergy Asthma Proc. 2022;43:78-84.
    PubMed     Abstract available


  32. RADOJICIC C
    Guidelines for management of hereditary angioedema: What is new? What is missing?
    Allergy Asthma Proc. 2022;43:12-19.
    PubMed     Abstract available


    November 2021
  33. DEMIRHAN A, Yildirim DD, Arikoglu T, Ozhan AK, et al
    A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children.
    Allergy Asthma Proc. 2021;42:e159-e166.
    PubMed     Abstract available


  34. VEZIR E, Hizal M, Cura Yayla B, Aykac K, et al
    Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
    Allergy Asthma Proc. 2021;42:522-529.
    PubMed     Abstract available


  35. PATEL GB, Chhiba KD, Chen MM, Guo A, et al
    COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Allergy Asthma Proc. 2021;42:515-521.
    PubMed     Abstract available


  36. BURROWS AG, Ellis AK
    Idiopathic anaphylaxis: Diagnosis and management.
    Allergy Asthma Proc. 2021;42:481-488.
    PubMed     Abstract available


  37. VERONEZ CL, Christiansen SC, Smith TD, Riedl MA, et al
    COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
    Allergy Asthma Proc. 2021;42:506-514.
    PubMed     Abstract available


  38. PAN R, Li Q, Zhu X, Zhou Y, et al
    Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.
    Allergy Asthma Proc. 2021;42:e167-e173.
    PubMed     Abstract available


  39. OLGAC M, Guler SD, Demir S, Unal D, et al
    Paucigranulocytic asthma: Do sputum macrophages matter?
    Allergy Asthma Proc. 2021;42:530-536.
    PubMed     Abstract available


  40. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Safety of ciclesonide in children with asthma: A review of randomized controlled trials.
    Allergy Asthma Proc. 2021;42:471-480.
    PubMed     Abstract available


  41. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Review of efficacy of ciclesonide for the treatment of asthma in children.
    Allergy Asthma Proc. 2021;42:461-470.
    PubMed     Abstract available


  42. WALLACE DV
    Treatment options for chronic rhinosinusitis with nasal polyps.
    Allergy Asthma Proc. 2021;42:450-460.
    PubMed     Abstract available


    September 2021
  43. PAPIA F, Bellia C, Uasuf CG
    Tropomyosin: A panallergen that causes a worldwide allergic problem.
    Allergy Asthma Proc. 2021;42:e145-e151.
    PubMed     Abstract available


  44. AYDOGAN M, Topal E, Yakici N, Acar HC, et al
    Food-induced anaphylaxis in early childhood and factors associated with its severity.
    Allergy Asthma Proc. 2021;42:e135-e144.
    PubMed     Abstract available


  45. SPERGEL JM, Blaiss MS, Lio P, Kessel A, et al
    Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.
    Allergy Asthma Proc. 2021;42:425-431.
    PubMed     Abstract available


  46. ARROLIGA ME, Dhanani K, Arroliga AC, Huddleston PS, et al
    Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.
    Allergy Asthma Proc. 2021;42:395-399.
    PubMed     Abstract available


  47. NELSON HS
    How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?
    Allergy Asthma Proc. 2021;42:368-377.
    PubMed     Abstract available


  48. BELLANTI JA, Settipane RA
    Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.
    Allergy Asthma Proc. 2021;42:365-367.
    PubMed    


  49. CAN BOSTAN O, Tuncay G, Damadoglu E, Karakaya G, et al
    Effect of COVID-19 on hereditary angioedema activity and quality of life.
    Allergy Asthma Proc. 2021;42:403-408.
    PubMed     Abstract available


  50. ARSENAULT S, Hoofman J, Poowuttikul P, Secord E, et al
    Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic.
    Allergy Asthma Proc. 2021;42:400-402.
    PubMed     Abstract available


  51. SARIOGLU N, Yalcin AD, Sahin F, Soyyigit S, et al
    Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study.
    Allergy Asthma Proc. 2021;42:e152-e158.
    PubMed     Abstract available


  52. XU H, Gao Y, Xie Y, Liang X, et al
    Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.
    Allergy Asthma Proc. 2021;42:e127-e134.
    PubMed     Abstract available


  53. KOCHIS S, Keet C, Claus LE, Hairston T, et al
    Caregiver perceptions and attitudes associated with oral immunotherapy on social media.
    Allergy Asthma Proc. 2021;42:432-438.
    PubMed     Abstract available


    August 2021
  54. BELLANTI JA
    COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.
    Allergy Asthma Proc. 2021 Aug 9. doi: 10.2500/aap.2021.42.210063.
    PubMed     Abstract available


    July 2021
  55. DZIEWA I, Hahn T, Bhardwaj N
    Persistent urticarial rash in a newborn.
    Allergy Asthma Proc. 2021;42:357-361.
    PubMed     Abstract available


  56. MANNING ME, Kashkin JM
    Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
    Allergy Asthma Proc. 2021;42:274-282.
    PubMed     Abstract available


  57. ZHU WJ, Liu Y, Wang G, Deng K, et al
    Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study.
    Allergy Asthma Proc. 2021 Jul 14. doi: 10.2500/aap.2021.42.210052.
    PubMed     Abstract available


  58. JUNG M, Kim MJ, Kim S, Kyung Y, et al
    Effect of prenatal phthalate exposure on childhood atopic dermatitis: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2021;42:e116-e125.
    PubMed     Abstract available


  59. ENGIN A, Oktelik FB, Gelincik A, Sin A, et al
    The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice.
    Allergy Asthma Proc. 2021;42:350-356.
    PubMed     Abstract available


  60. MEADOWS JA, Yu S, Hass SL, Guerin A, et al
    Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
    Allergy Asthma Proc. 2021;42:333-342.
    PubMed     Abstract available


  61. ENDO T, Asaka D, Nakayama T, Saito S, et al
    Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores.
    Allergy Asthma Proc. 2021;42:293-300.
    PubMed     Abstract available


  62. WERNER MT, Bosso JV
    Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2021;42:283-292.
    PubMed     Abstract available


  63. BELLANTI JA, Settipane RA
    COVID-19: A continuing challenge for the allergist/immunologist.
    Allergy Asthma Proc. 2021;42:263-266.
    PubMed    


  64. BEYAZ S, Demir S, Oztop N, Karadag P, et al
    Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticarial.
    Allergy Asthma Proc. 2021;42:e107-e115.
    PubMed     Abstract available


  65. SITEK AN, Ade JM, Chiarella SE, Divekar RD, et al
    Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2021;42:267-273.
    PubMed     Abstract available


  66. OCAK M, Akarsu A, Sahiner UM, Soyer O, et al
    Food protein-induced enterocolitis syndrome: Current practices in oral food challenge.
    Allergy Asthma Proc. 2021;42:343-349.
    PubMed     Abstract available


  67. OCAK M, Nain E, Akarsu A, Sahiner UM, et al
    Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
    Allergy Asthma Proc. 2021;42:325-332.
    PubMed     Abstract available


  68. JOHNSON FA, Wirth M, Zhu Z, Hahn J, et al
    Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment.
    Allergy Asthma Proc. 2021;42:317-324.
    PubMed     Abstract available


  69. KWONG KY, Lu YZ, Jauregui E, Scott L, et al
    Persistent airflow obstruction in inner-city children with asthma.
    Allergy Asthma Proc. 2021;42:310-316.
    PubMed     Abstract available


    May 2021
  70. WINDERS T, DuBuske L, Bukstein DA, Meltzer EO, et al
    Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies.
    Allergy Asthma Proc. 2021 May 24. doi: 10.2500/aap.2021.42.210035.
    PubMed     Abstract available


  71. TOSCA MA, Licari A, Marseglia GL, Ciprandi G, et al
    COVID-19 in Italian children and adolescents: The role of allergy and asthma.
    Allergy Asthma Proc. 2021;42:e101-e102.
    PubMed    


  72. TURGAY YAGMUR I, Yilmaz Topal O, Kulhas Celik I, Toyran M, et al
    Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood.
    Allergy Asthma Proc. 2021;42:e96-e100.
    PubMed     Abstract available


  73. BINGOL A, Uygun DFK, Akdemir M, Erengin H, et al
    Clinical phenotypes of childhood food allergies based on immune mechanisms: A multicenter study.
    Allergy Asthma Proc. 2021;42:e86-e95.
    PubMed     Abstract available


  74. KONIG B, Koch AN, Bellanti JA
    Studies of mitochondrial and nuclear DNA released from food allergen-activated neutrophils. Implications for non-IgE food allergy.
    Allergy Asthma Proc. 2021;42:e59-e70.
    PubMed     Abstract available


  75. ROBINSON LB, Arroyo AC, Cash RE, Rudders SA, et al
    Emergency department revisits and rehospitalizations among infants and toddlers for acute allergic reactions.
    Allergy Asthma Proc. 2021;42:247-256.
    PubMed     Abstract available


  76. PAPAIOANNOU AI, Mplizou M, Porpodis K, Fouka E, et al
    Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study.
    Allergy Asthma Proc. 2021;42:235-242.
    PubMed     Abstract available


  77. LARENAS-LINNEMANN DE, Ortega-Martell JA, Blandon-Vijil MV, Rodriguez-Perez N, et al
    Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction.
    Allergy Asthma Proc. 2021;42:187-197.
    PubMed     Abstract available


  78. BELLANTI JA, Settipane RA
    The allergist and IgE: The realization that allergic diseases are not all IgE mediated.
    Allergy Asthma Proc. 2021;42:183-186.
    PubMed    


  79. ALZAABI A, Idrees M, Behbehani N, Salah F, et al
    Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia.
    Allergy Asthma Proc. 2021;42:e77-e85.
    PubMed     Abstract available


  80. VAN ZELST CM, de Boer GM, Turk Y, van Huisstede A, et al
    Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study.
    Allergy Asthma Proc. 2021;42:e71-e76.
    PubMed     Abstract available


  81. AJEWOLE O, Lanlokun M, Dimanche S, Craig T, et al
    Short-term prophylaxis for children and adolescents with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:205-213.
    PubMed     Abstract available


  82. ZHANG S, Bernstein JA
    Mast cell activation syndrome: Myths and realities.
    Allergy Asthma Proc. 2021;42:198-204.
    PubMed     Abstract available


  83. RIEDL MA, Craig TJ, Banerji A, Aggarwal K, et al
    Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
    Allergy Asthma Proc. 2021;42:S17-S25.
    PubMed     Abstract available


  84. CRAIG TJ, Banerji A, Riedl MA, Best JM, et al
    Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.
    Allergy Asthma Proc. 2021;42:S11-S16.
    PubMed     Abstract available


  85. RADOJICIC C, Riedl MA, Craig TJ, Best JM, et al
    Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.
    Allergy Asthma Proc. 2021;42:S4-S10.
    PubMed     Abstract available


  86. BANERJI A, Riedl MA, Craig TJ, Radojicic C, et al
    Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.
    Allergy Asthma Proc. 2021;42:S1-S3.
    PubMed    


    March 2021
  87. KOLINSKY NC, Lockey RF
    Chlorhexidine: An important cause of perioperative anaphylaxis.
    Allergy Asthma Proc. 2021 Mar 22. doi: 10.2500/aap.2021.42.200060.
    PubMed     Abstract available


  88. WANG Q, Pittman L, Healey A, Chang J, et al
    Ideal body position for epinephrine autoinjector administration.
    Allergy Asthma Proc. 2021;42:147-152.
    PubMed     Abstract available


  89. CASTALDO AJ, Jervelund C, Corcoran D, Boysen HB, et al
    Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:108-117.
    PubMed     Abstract available


  90. ZHOU J, Chen S, Song Z
    Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
    Allergy Asthma Proc. 2021;42:e47-e54.
    PubMed     Abstract available


  91. PANDYA A, Gregory ER, Cherian S, Parashar S, et al
    Implementation of EMR-based standardized antibiotic desensitization protocols and its impact on providers.
    Allergy Asthma Proc. 2021;42:160-166.
    PubMed     Abstract available


  92. HAM Y, Sukerman ES, Lewis JS 2nd, Tucker KJ, et al
    Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation.
    Allergy Asthma Proc. 2021;42:153-159.
    PubMed     Abstract available


  93. PASSANISI S, Lombardo F, Crisafulli G, Salzano G, et al
    Novel diagnostic techniques and therapeutic strategies for IgE-mediated food allergy.
    Allergy Asthma Proc. 2021;42:124-130.
    PubMed     Abstract available



  94. For the patient.
    Allergy Asthma Proc. 2021;42:180.
    PubMed    


  95. GENEROSO AJ, Goldman JA, Wolff AH
    A 62-year-old man with new-onset bullae.
    Allergy Asthma Proc. 2021;42:175-179.
    PubMed     Abstract available


  96. BUYUK YAYTOKGIL S, Guvenir H, Kulhas Celik I, Yilmaz Topal O, et al
    Evaluation of drug patch tests in children.
    Allergy Asthma Proc. 2021;42:167-174.
    PubMed     Abstract available


  97. COHEN JS, Agbim C, Hrdy M, Mottla ME, et al
    Epinephrine autoinjector prescription filling after pediatric emergency department discharge.
    Allergy Asthma Proc. 2021;42:142-146.
    PubMed     Abstract available


  98. SWEIS AM, Locke TB, Ig-Izevbekhai KI, Lin TC, et al
    Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2021;42:136-141.
    PubMed     Abstract available


  99. CAO Y, Liu S, Zhi Y
    Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:131-135.
    PubMed     Abstract available


  100. ANAGNOSTOU A
    Weighing the benefits and risks of oral immunotherapy in clinical practice.
    Allergy Asthma Proc. 2021;42:118-123.
    PubMed     Abstract available


  101. BELLANTI JA, Settipane RA
    Hereditary angioedema again revisited.
    Allergy Asthma Proc. 2021;42:105-107.
    PubMed    


    February 2021
  102. AKSU K, Yesilkaya S, Topel M, Turkyilmaz S, et al
    COVID-19 in a patient with severe asthma using mepolizumab.
    Allergy Asthma Proc. 2021 Feb 3. doi: 10.2500/aap.2021.42.200125.
    PubMed     Abstract available


    January 2021
  103. CHOW TG, McConnell J, Lee MJ
    A 2-year-old girl with periprocedural anaphylaxis.
    Allergy Asthma Proc. 2021;42:97-99.
    PubMed     Abstract available


  104. YORMAZ B, Menevse E, Cetin N, Esin Celik Z, et al
    Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study.
    Allergy Asthma Proc. 2021;42:e30-e39.
    PubMed     Abstract available


  105. TASHKIN DP, Koltun A, Wallace R
    A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Allergy Asthma Proc. 2021;42:30-35.
    PubMed     Abstract available


  106. JOHNSTON DT, Henry Li H, Craig TJ, Bernstein JA, et al
    Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.
    Allergy Asthma Proc. 2021;42:22-29.
    PubMed     Abstract available


  107. ZOU X, Hu H, Huang Z, Liao C, et al
    Serum levels of specific immunoglobulin E to Dermatophagoides pteronyssinus allergen components in patients with allergic rhinitis or/and asthma.
    Allergy Asthma Proc. 2021;42:e40-e46.
    PubMed     Abstract available


  108. BERNSTEIN DI, Wurtzen PA, DuBuske L, Blaiss MS, et al
    Allergy to oak pollen in North America.
    Allergy Asthma Proc. 2021;42:43-54.
    PubMed     Abstract available


  109. BISYUK Y, DuBuske I, DuBuske LM
    Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy.
    Allergy Asthma Proc. 2021;42:36-42.
    PubMed     Abstract available


  110. WOLFSON AR, Banerji A
    Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions.
    Allergy Asthma Proc. 2021;42:16-21.
    PubMed     Abstract available


  111. BELLANTI JA, Settipane RA
    The challenge of COVID-19 that permeates the practice of allergy/immunology.
    Allergy Asthma Proc. 2021;42:1-4.
    PubMed    


  112. OZDEN MAT D, Firat S, Aksu K, Aksu F, et al
    Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis.
    Allergy Asthma Proc. 2021;42:e25-e29.
    PubMed     Abstract available


  113. MAGEN E, Waitman DA, Kahan NR
    Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2021;42:e17-e24.
    PubMed     Abstract available


  114. TIOTIU A
    Applying personalized medicine to adult severe asthma.
    Allergy Asthma Proc. 2021;42:e8-e16.
    PubMed     Abstract available


  115. SAVARESE L, Mormile I, Bova M, Petraroli A, et al
    Psychology and hereditary angioedema: A systematic review.
    Allergy Asthma Proc. 2021;42:e1-e7.
    PubMed     Abstract available


  116. AYDIN O, Sozener ZC, Demirel YS, Secil D, et al
    Baker's asthma in bread factory workers.
    Allergy Asthma Proc. 2021;42:72-77.
    PubMed     Abstract available


  117. DUDIAK GJ, Popyack J, Grimm C, Tyson S, et al
    Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations.
    Allergy Asthma Proc. 2021;42:65-71.
    PubMed     Abstract available


    December 2020
  118. STONE B, Rance K, Waddell D, Aagren M, et al
    Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence.
    Allergy Asthma Proc. 2020 Dec 23. doi: 10.2500/aap.2021.42.200114.
    PubMed     Abstract available


  119. PITLICK MM, Joshi AY
    Considerations for asthma management and viral transmission in the era of COVID-19.
    Allergy Asthma Proc. 2020 Dec 23. doi: 10.2500/aap.2021.42.200111.
    PubMed     Abstract available


    November 2020

  120. Abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, August 16-18, 2020.
    Allergy Asthma Proc. 2020;41:458-460.
    PubMed    


  121. BIELORY L
    Allergic inflammation of the anterior surface of the eye.
    Allergy Asthma Proc. 2020;41:449-453.
    PubMed     Abstract available


  122. KULHAS CELIK I, Turgay Yagmur I, Yilmaz Topal O, Toyran M, et al
    Diagnostic value and safety of penicillin skin tests in children with immediate penicillin allergy.
    Allergy Asthma Proc. 2020;41:442-448.
    PubMed     Abstract available


  123. ROSLOFF DA, Patel K, Feustel PJ, Celestin J, et al
    Criteria positive and criteria negative anaphylaxis, with a focus on undifferentiated somatoform idiopathic anaphylaxis: A review and case series.
    Allergy Asthma Proc. 2020;41:436-441.
    PubMed     Abstract available


  124. HA EK, Kim JH, Lee SW, Jee HM, et al
    Atopic dermatitis: Correlation of severity with allergic sensitization and eosinophilia.
    Allergy Asthma Proc. 2020;41:428-435.
    PubMed     Abstract available


  125. BELLANTI JA, Settipane RA
    The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
    Allergy Asthma Proc. 2020;41:395-396.
    PubMed    


    September 2020
  126. DENG K, Zhang X, Liu Y, Cheng GP, et al
    Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study.
    Allergy Asthma Proc. 2020;41:348-356.
    PubMed     Abstract available


  127. ORTEGA H, Hahn B, Bogart M, Bell CF, et al
    Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base.
    Allergy Asthma Proc. 2020;41:341-347.
    PubMed     Abstract available


    July 2020
  128. SOENJOYO KR, Nadkarni N, Koh MS
    Comparison of exacerbation phenotypes among patients with severe asthma.
    Allergy Asthma Proc. 2020;41:e67-e79.
    PubMed     Abstract available


  129. YANG L, Zhao Q, Wang S
    The role of serum periostin in the diagnosis of asthma: A meta-analysis.
    Allergy Asthma Proc. 2020;41:240-247.
    PubMed     Abstract available


    May 2020
  130. CHIPPS B, Mosnaim G, Mathur SK, Shaikh A, et al
    Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma.
    Allergy Asthma Proc. 2020 May 15. doi: 10.2500/aap.2020.41.200036.
    PubMed     Abstract available



  131. For the PatientWheezing in childhood and risk of asthma.
    Allergy Asthma Proc. 2020;41:224.
    PubMed    


  132. LURIA CJ, Sitarik AR, Havstad S, Zoratti EM, et al
    Association between asthma symptom scores and perceived stress and trait anxiety in adolescents with asthma.
    Allergy Asthma Proc. 2020;41:210-217.
    PubMed     Abstract available


  133. BOBROWSKA-KORZENIOWSKA M, Jerzynska J, Mital M, Podlecka D, et al
    Effectiveness of ongoing face-to-face anti-tobacco intervention in children with asthma.
    Allergy Asthma Proc. 2020;41:198-203.
    PubMed     Abstract available


  134. YILMAZ I
    Biologics for oral corticosteroid-dependent asthma.
    Allergy Asthma Proc. 2020;41:151-157.
    PubMed     Abstract available


  135. BELLANTI JA, Settipane RA
    The continuing "1000 faces of asthma".
    Allergy Asthma Proc. 2020;41:147-150.
    PubMed    


    March 2020
  136. WUFUER D, Aierken H, Fang Y, Simayi M, et al
    Incidence of depression and its influencing factors in 387 patients with asthma from Xinjiang, China.
    Allergy Asthma Proc. 2020;41:e45-e53.
    PubMed     Abstract available


  137. MOHAMMADZADEH I, Darvish S, Qujeq D, Hajiahmadi M, et al
    Association of serum 25-OH vitamin D(3) with serum IgE and the Pediatric Asthma Severity Score in patients with pediatric asthma.
    Allergy Asthma Proc. 2020;41:126-133.
    PubMed     Abstract available


  138. SHAHEEN MS, Silverberg JI
    Association of asthma with osteopenia, osteoporosis, osteomalacia, and fractures.
    Allergy Asthma Proc. 2020;41:112-119.
    PubMed     Abstract available


  139. SIMON TL, Kalina U, Laske R, Mycroft S, et al
    Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema.
    Allergy Asthma Proc. 2020;41:99-107.
    PubMed     Abstract available


    January 2020
  140. WEST LJ, Petrov AA, Fajt ML
    A 72-year-old woman with periorbital swelling.
    Allergy Asthma Proc. 2020;41:e33-e36.
    PubMed     Abstract available


  141. RAJAGOPAL TV, Kant S, Verma SK, Kushwaha RAS, et al
    Aspergillus sensitization in bronchial asthma: A separate phenotype.
    Allergy Asthma Proc. 2020;41:e26-e32.
    PubMed     Abstract available


  142. ZHU K, Xiang L, Shen K
    Efficacy of Chinese Children's Asthma Action Plan in the management of children with asthma.
    Allergy Asthma Proc. 2020;41:e3-e10.
    PubMed     Abstract available



  143. For the Patient.
    Allergy Asthma Proc. 2020;41:70.
    PubMed    


  144. MUSTAFA SS, Vadamalai K, Bingemann T, Ramsey A, et al
    Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy.
    Allergy Asthma Proc. 2020;41:52-58.
    PubMed     Abstract available


    November 2019
  145. GREENBERGER PA
    Lessons learned from clinical trials of asthma.
    Allergy Asthma Proc. 2019;40:410-413.
    PubMed     Abstract available


  146. AGNIHOTRI NT, Saltoun C
    Acute severe asthma (status asthmaticus).
    Allergy Asthma Proc. 2019;40:406-409.
    PubMed     Abstract available


  147. GREENBERGER PA
    Potentially (near) fatal asthma.
    Allergy Asthma Proc. 2019;40:403-405.
    PubMed     Abstract available


  148. KWAH JH, Peters AT
    Asthma in adults: Principles of treatment.
    Allergy Asthma Proc. 2019;40:396-402.
    PubMed     Abstract available


  149. DEVONSHIRE AL, Kumar R
    Pediatric asthma: Principles and treatment.
    Allergy Asthma Proc. 2019;40:389-392.
    PubMed     Abstract available


  150. PADEM N, Saltoun C
    Classification of asthma.
    Allergy Asthma Proc. 2019;40:385-388.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: